Associated Papers
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer.
Schaufler D et al.
Npj Precision Oncology, 2021
Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors.
Yamamoto K et al.
Elife, 2016
27304073 (PubMed )
Supplement: elife-14709-supp1.xlsx › Supplementary_Information_1B
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
Tavtigian SV et al.
American Journal of Human Genetics, 2009
Select a paper to view details